Roche is committed to working with the global community to develop solutions to the challenges of the SARS-CoV-2 (COVID-19) pandemic. We believe that one important way in which the world can win this fight is through the sharing of knowledge and healthcare data to better inform patient care and health system decision making. To help achieve this, we have assembled a group of like-minded public and private organizations with a common mission and vision to bring actionable COVID-19 intelligence to patients, frontline healthcare providers, institutions, supply chains, and government.
Alberta Machine Intelligence Institute (Amii) — One of Canada’s three centres of AI excellence as part of the Pan-Canadian AI Strategy, Amii is an Alberta-based non-profit institute that supports world-leading research in artificial intelligence and machine learning and translates scientific advancement into industry adoption. Amii grows AI capabilities through advancing leading-edge research, delivering exceptional educational offerings and providing business advice – all with the goal of building in-house AI capabilities.
doc.ai is a Palo-Alto-based, deep learning company. We build “ai-ssembly lines” and operate a virtual, site-less clinical trial platform/market that continuously processes data for payers and pharma. We’ve also made notable breakthroughs in privacy-preserving techniques like federated learning to advance research and accelerate better health outcomes through the safe exchange of data. Our consumer offerings include a suite of companion apps for research studies, health algorithm testing, mental health, and DNA exploration.
NVIDIA equips the world’s leading healthcare institutions with advanced tools to tackle interoperable data and meet the increasing demand for personalized medicine and next-generation clinics. Use NVIDIA platforms to develop intelligent applications unique to your workflows, and accelerate areas such as image analysis, scientific research, and drug discovery.
RGAX was established in 2015 as the “transformation engine” of Reinsurance Group of America (RGA) – the largest global reinsurer focused exclusively on the life and health industries – and as an extension of RGA’s decades-long commitment to innovation. RGAX builds on this legacy of continuous innovation, partnering with clients and entrepreneurs to address existing challenges, explore new opportunities, and build the future of life and health insurance. Having established an industry-leading combination of talent, technologies and best practices, RGAX helps carriers improve longevity, increase the health span of people around the world, and make significant strides to closing the global insurance coverage gap.
Self Care Catalysts is a patient-centered digital therapeutics, intelligence and analytics company. We power population health interventions, real world evidence research, and digital therapeutics through proprietary digital tools and integration with external remote monitoring devices to inform clinical care, research and behavior change interventions. Our belief is that when patients are informed, respected, and engaged, they make better choices. Better choices mean better health outcomes. Therefore, it is important that patients’ views are well-represented in healthcare through the generation of real world evidence.
COVID-19 Health Storylines is a free app that empowers patients around the world to take control of their self care. A tool that helps manage health during the pandemic and beyond, COVID-19 Health Storylines allows patients to assess their COVID risk, monitor symptoms, learn the best ways to protect themselves and others, and contribute data to ease the burden on health systems.
ThinkData Works Inc. makes accessing data from anywhere easy. By creating the most efficient solution to stream data from any public or private source in the world, ThinkData's platform, Namara, enables data scientists to access more data, offload prep and processing overhead onto automated pipelines, and significantly increase the confidence they have in plugging new data into products, models and solutions. To learn more, please visit Namara and connect on Twitter and on LinkedIn.
Vector Institute is an independent, not-for-profit corporation dedicated to advancing artificial intelligence, excelling in machine learning and deep learning. Our vision is to drive excellence and leadership in Canada’s knowledge, creation, and use of AI to foster economic growth and improve the lives of Canadians. The Vector Institute is funded by the Province of Ontario, the Government of Canada through the Pan-Canadian AI Strategy administered by CIFAR, and industry sponsors from across the Canadian economy.